Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Rating of "Buy" from Brokerages

Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Get Free Report) has been given a consensus rating of "Buy" by the five analysts that are covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among analysts that have covered the stock in the last year is $8.63.

Several research analysts have commented on BIOX shares. Wall Street Zen upgraded shares of Bioceres Crop Solutions from a "sell" rating to a "hold" rating in a research report on Saturday, June 21st. Oppenheimer lowered their price objective on shares of Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating for the company in a research report on Tuesday, April 22nd.

Bioceres Crop Solutions Trading Down 10.7%

Shares of BIOX stock opened at $4.41 on Tuesday. The company has a quick ratio of 0.74, a current ratio of 1.02 and a debt-to-equity ratio of 0.22. Bioceres Crop Solutions has a 12-month low of $3.51 and a 12-month high of $11.78. The firm has a 50 day moving average price of $4.64 and a two-hundred day moving average price of $5.06. The company has a market capitalization of $276.55 million, a PE ratio of -31.50, a price-to-earnings-growth ratio of 1.40 and a beta of 0.41.

Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last released its quarterly earnings results on Wednesday, May 21st. The company reported ($0.02) earnings per share for the quarter, beating analysts' consensus estimates of ($0.10) by $0.08. Bioceres Crop Solutions had a negative net margin of 2.14% and a negative return on equity of 2.37%. The company had revenue of $59.60 million during the quarter, compared to the consensus estimate of $61.80 million. As a group, analysts predict that Bioceres Crop Solutions will post -0.05 earnings per share for the current year.

Institutional Trading of Bioceres Crop Solutions

A number of hedge funds and other institutional investors have recently modified their holdings of BIOX. Jones Financial Companies Lllp grew its stake in shares of Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock worth $25,000 after buying an additional 5,339 shares during the last quarter. Bank of America Corp DE grew its stake in shares of Bioceres Crop Solutions by 186.8% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock worth $35,000 after buying an additional 3,735 shares during the last quarter. Jump Financial LLC bought a new stake in shares of Bioceres Crop Solutions during the fourth quarter worth $72,000. Avanza Fonder AB bought a new stake in shares of Bioceres Crop Solutions during the first quarter worth $72,000. Finally, PDT Partners LLC bought a new stake in shares of Bioceres Crop Solutions during the first quarter worth $81,000. Institutional investors own 17.68% of the company's stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.